Observational studyInternational journal of cancer2022

A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISE.

Heather Payne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.